Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery

Area of Science:

• Cardiology
• Pharmacology
• Surgical Outcomes

Background:

• Statin therapy is proven to reduce cardiovascular events in general populations.
• Preoperative statin use has shown benefits in non-cardiac vascular surgery.
• The impact of preoperative statins on outcomes after coronary artery bypass graft (CABG) surgery requires investigation.

Purpose of the Study:

• To investigate the influence of preoperative statin therapy on adverse outcomes in patients undergoing primary CABG surgery.
• To determine if preoperative statin use is independently associated with reduced mortality and morbidity after CABG.
• To assess the association between preoperative statin therapy and specific postoperative complications.

Main Methods:

• Retrospective cohort study of 1663 patients undergoing primary CABG with cardiopulmonary bypass (CPB).
• Patients were categorized into two groups: those receiving preoperative statins and those not.
• Multivariate logistic regression and propensity-matched analysis were used to control for confounding factors.

Main Results:

• Preoperative statin therapy was independently associated with a significant reduction (approx. 50%) in 30-day all-cause mortality (1.80% vs. 3.75%).
• The adjusted odds ratio for early mortality with preoperative statin use was 0.53.
• No significant association was found between preoperative statin therapy and reduced risk of postoperative myocardial infarction, stroke, or renal dysfunction.

Conclusions:

• Preoperative statin therapy may significantly reduce the risk of early mortality following primary CABG surgery.
• The findings suggest a potential protective effect of statins administered before cardiac surgery.
• Further research may explore the mechanisms and broader implications of this finding.